Scienture Holdings, Inc.
- Last sale
- Nov 12, 2026 · -4.25%
- Market cap
- $120.32M
- 41.06M shares
- Filings
- 508
Q2 2026+215.9% FY25 yoy
Q2 2026N/M FY25 yoy
Q2 2026N/M FY25 yoy
FY 2024derivedN/M FY24 yoy
Q2 2026N/M FY25 yoy
Q2 2026+2,062.3% FY25 yoy
- $120.32M
- —
- 278.8×
- 1.9×
- —
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $431,609 | reported | |
| FY 2024 | 2024-12-31 | $136,643 | reported | |
| FY 2023 | 2023-12-31 | $1,363,830 revised | reported | |
| FY 2022 | 2022-12-31 | $10,250,168 revised | reported | |
| FY 2021 | 2021-12-31 | $9,889,433 | reported | |
| FY 2020 | 2020-12-31 | $17,122,520 | reported | |
| FY 2019 | 2019-12-31 | $7,436,264 | reported | |
| FY 2018 | 2018-12-31 | $3,831,778 | reported | |
| FY 2017 | 2017-12-31 | $2,931,280 | reported | |
| FY 2016 | 2016-12-31 | $2,481,866 | reported | |
| FY 2015 | 2015-12-31 | $2,912,525 revised | reported | |
| FY 2014 | 2014-12-31 | $1,496,227 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2024 | $14.86M | — | $14.86M | — | 12.52M sh | +789.9% | — |
Segments
LineFY2024ShareChange
Integra$136.64K100%−90.0%
Community Specialty Pharmacy, LLC———
Community Specialty Pharmacy, LLC———
Integra———
Integra Pharma LLC———
Integra Pharma, LLC———
Other Segments———
Other———
Total$136.64K
Pharmaceutical preparations
Scienture Holdings, Inc. is the 229th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
YARWYarrow Bioscience, Inc.$570.0K13.8%4,646.1%$52.0MSLNSilence Therapeutics plc$559.0K98.7%15,851.9%$2.8BQUCYQuantum Cyber N.V.$537.1K39.9%3,018.3%$49.2MMREOMereo BioPharma Group plc$500.0K—8,375.6%$243.3M
SCNXScienture Holdings, Inc. (this company)$431.6K215.9%9,618.0%$120.3M
MNOVMedicinova Inc$409.7K—2,928.8%$72.0MCANFCan-Fite BioPharma Ltd.$405.0K39.9%2,426.7%$1.9MPVCTProvectus Biopharmaceuticals, Inc.$336.1K45.5%1,615.8%$29.2MALLRAllarity Therapeutics, Inc.$320.0K—3,509.7%$14.6MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Scienture Holdings, Inc. · CIK 1382574 · Engraved from SEC EDGAR